Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rosemarie A. Hederer"'
Autor:
Christine Guntermann, Denis R. Alexander, János Szöllosi, Nigel Miller, Rosemarie A. Hederer, Geoffrey Hale, Sándor Damjanovich, Péter Nagy
Publikováno v:
International Immunology. 12:505-516
Campath-1H, a humanized mAb undergoing clinical trials for treatment of leukemia, transplantation and autoimmune diseases, produces substantial lymphocyte depletion in vivo. The antibody binds to CD52, a highly glycosylated molecule attached to the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::407aff1aa8b994d1a6c94c034ed9d756
https://doi.org/10.1093/intimm/12.4.505
https://doi.org/10.1093/intimm/12.4.505
Autor:
Pat Fryer, Peter Robinson, Kyuhei Tomonari, Stephen Griffiths, Rosemarie A. Hederer, Margaret Millrain
Publikováno v:
International Immunology. 4:1137-1143
KT16, like other anti-Thy-1 antibodies, induces T cell aggregation. Protein A-gold labelling shows the antibody to be concentrated along areas of intercellular contacts. Electron micrographs of KT16 treated T cells reveal a consistent type of junctio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15bed8cfd50c23dbcc5902770af171f1
https://doi.org/10.1093/intimm/4.10.1137
https://doi.org/10.1093/intimm/4.10.1137
Publikováno v:
Transplantation. 60:1274
Xenoreactive antibodies (XAb) play a major role in the rejection of xenografts. In this study, human IgG XAb that bind to xenoantigens expressed by porcine aortic endothelial cells (PAEC) were characterized, together with their corresponding xenoanti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd4a1ed68f730c2ffed2bb9e2967da2b
https://doi.org/10.1097/00007890-199512000-00015
https://doi.org/10.1097/00007890-199512000-00015